Surgery outcomes for myopic foveoschisis
Part of Eyes & vision clinical trials.
This study is looking at how well people do after eye surgery for a condition called myopic foveoschisis, which causes a part of the retina to swell. The study will check if your vision improves after surgery and look for signs of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 90 years old.
- You have a diagnosis of high myopia (severe nearsightedness).
- You have myopic foveoschisis that has not responded to other treatments, and you are planning to have surgery.
- You do not have other serious eye diseases, such as retinal detachment, macular scarring, or uncontrolled glaucoma.
- You are able to complete the study's vision tests.
- You are willing to have your eye surgery and vision problems followed for up to 6 months.
- fitModel
- tags
- fit
- questions
- include_if
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares ten different surgical methods for repairing full-thickness macular holes—small breaks in the central part of the retina that blur vision. You'd be in the study to help doctors learn which technique works best at restoring sight.
This study compares two surgical methods for repairing large macular holes, a condition that affects the center of the retina and can blur vision. The goal is to see which technique works better for closing the hole and improving eyesight.
This study compares how different types of glaucoma surgery affect your daily life and well-being. If you need glaucoma surgery, you may join to help doctors understand which procedure works best from a patient's perspective.
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
This study uses detailed eye scans (OCT and OCTA) to predict how well anti-VEGF injections will work in the long run for people with high myopia and an eye condition called myopic choroidal neovascularization (abnormal blood vessel growth caused by myopia). If you fit the criteria, participating could help doctors know if these injections are a good option for you.
This trial tests a new treatment for people with a specific type of age-related macular degeneration (AMD) that has not improved after standard anti-VEGF injections. The goal is to see if it can stop vision loss and reduce retinal damage.
Hear when a new Myopic Traction Maculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.